Investigating the impact of nanoparticle size on active and passive tumor targeting efficiency.
暂无分享,去创建一个
Gang Zheng | Edward A. Sykes | Warren C. W. Chan | E. A. Sykes | W. Chan | G. Zheng | Juan Chen | Juan Chen
[1] Jiwon Bang,et al. Surface engineering of inorganic nanoparticles for imaging and therapy. , 2013, Advanced drug delivery reviews.
[2] Iseult Lynch,et al. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. , 2011, Journal of the American Chemical Society.
[3] R. Jain,et al. Delivering nanomedicine to solid tumors , 2010, Nature Reviews Clinical Oncology.
[4] S M Moghimi,et al. Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.
[5] Brahim Lounis,et al. Cathepsin L digestion of nanobioconjugates upon endocytosis. , 2009, ACS nano.
[6] M. Amiji,et al. Biodistribution and pharmacokinetic analysis of long-circulating thiolated gelatin nanoparticles following systemic administration in breast cancer-bearing mice. , 2007, Journal of pharmaceutical sciences.
[7] Tanya S. Hauck,et al. Exploring Primary Liver Macrophages for Studying Quantum Dot Interactions with Biological Systems , 2010, Advanced materials.
[8] Warren C W Chan,et al. Mediating tumor targeting efficiency of nanoparticles through design. , 2009, Nano letters.
[9] C. Unger,et al. In vitro and in vivo Efficacy of Acid-Sensitive Transferrin and Albumin Doxorubicin Conjugates in a Human Xenograft Panel and in the MDA-MB-435 Mamma Carcinoma Model , 2000, Journal of drug targeting.
[10] Michael M. Schmidt,et al. A modeling analysis of the effects of molecular size and binding affinity on tumor targeting , 2009, Molecular Cancer Therapeutics.
[11] Wolfgang A. Weber,et al. Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging , 2007, Proceedings of the National Academy of Sciences.
[12] S. Nie,et al. A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands. , 2010, ACS nano.
[13] May D. Wang,et al. In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags , 2008, Nature Biotechnology.
[14] Warren C W Chan,et al. Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. , 2007, Nano letters.
[15] Mark E. Davis,et al. Targeting kidney mesangium by nanoparticles of defined size , 2011, Proceedings of the National Academy of Sciences.
[16] M. Uesaka,et al. Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. , 2011, Nature nanotechnology.
[17] M. Dobrovolskaia,et al. Immunological properties of engineered nanomaterials , 2007, Nature Nanotechnology.
[18] M. Kurfürst. Detection and molecular weight determination of polyethylene glycol-modified hirudin by staining after sodium dodecyl sulfate-polyacrylamide gel electrophoresis. , 1992, Analytical biochemistry.
[19] F. Kiessling,et al. Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[20] Warren C W Chan,et al. Fluorescence‐Tagged Gold Nanoparticles for Rapidly Characterizing the Size‐Dependent Biodistribution in Tumor Models , 2012, Advanced healthcare materials.
[21] D. Wei,et al. Discarded free PEG-based assay for obtaining the modification extent of pegylated proteins. , 2007, Talanta.
[22] Mark E. Davis,et al. Impact of tumor‐specific targeting and dosing schedule on tumor growth inhibition after intravenous administration of siRNA‐containing nanoparticles , 2008, Biotechnology and bioengineering.
[23] Michael S. Strano,et al. Size-dependent cellular uptake and expulsion of single-walled carbon nanotubes: single particle tracking and a generic uptake model for nanoparticles. , 2009, ACS nano.
[24] Stephen J. Lomnes,et al. Tissue-like phantoms for near-infrared fluorescence imaging system assessment and the training of surgeons. , 2006, Journal of biomedical optics.
[25] Mark E. Davis,et al. Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles , 2009, Proceedings of the National Academy of Sciences.
[26] Huajian Gao,et al. Mechanics of receptor-mediated endocytosis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[27] G. Adams,et al. High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules. , 2001, Cancer research.
[28] R K Jain,et al. Transport of fluid and macromolecules in tumors. III. Role of binding and metabolism. , 1991 .
[29] Warren C W Chan,et al. The effect of nanoparticle size, shape, and surface chemistry on biological systems. , 2012, Annual review of biomedical engineering.
[30] R K Jain,et al. Transport of fluid and macromolecules in tumors. I. Role of interstitial pressure and convection. , 1989, Microvascular research.
[31] W. Chan,et al. Synthesis and surface modification of highly monodispersed, spherical gold nanoparticles of 50-200 nm. , 2009, Journal of the American Chemical Society.
[32] U. Nielsen,et al. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. , 2006, Cancer research.
[33] Manuela Semmler-Behnke,et al. Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[34] Warren C W Chan,et al. Nanoparticle-mediated cellular response is size-dependent. , 2008, Nature nanotechnology.
[35] G. Ulrich Nienhaus,et al. Impact of protein modification on the protein corona on nanoparticles and nanoparticle-cell interactions. , 2014, ACS nano.
[36] Kenneth A. Dawson,et al. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts , 2008, Proceedings of the National Academy of Sciences.
[37] Andrew Emili,et al. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. , 2012, Journal of the American Chemical Society.
[38] Keishiro Tomoda,et al. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. , 2008, Colloids and surfaces. B, Biointerfaces.
[39] B. Murray,et al. The effect of geometry on capillary wall dose for boron neutron capture therapy. , 1976, Physics in medicine and biology.
[40] Susan Newbigging,et al. In vivo quantum-dot toxicity assessment. , 2010, Small.
[41] Philip M. Kelly,et al. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. , 2013, Nature nanotechnology.
[42] Subra Suresh,et al. Size‐Dependent Endocytosis of Nanoparticles , 2009, Advanced materials.
[43] Dai Fukumura,et al. Multistage nanoparticle delivery system for deep penetration into tumor tissue , 2011, Proceedings of the National Academy of Sciences.
[44] Warren C. W. Chan,et al. Polyethylene glycol backfilling mitigates the negative impact of the protein corona on nanoparticle cell targeting. , 2014, Angewandte Chemie.
[45] S. Krantz,et al. Transferrin receptor number, synthesis, and endocytosis during erythropoietin-induced maturation of Friend virus-infected erythroid cells. , 1986, The Journal of biological chemistry.